Nu Skin Enterprises Inc. (NUS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
75 WEST CENTER ST PROVO, UT 84601 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 268 | 279 | 355 | 424 | 344 | 398 | |||
| Cash and cash equivalents | 256 | 265 | 340 | 403 | 336 | 387 | |||
| Short-term investments | 12 | 14 | 15 | 21 | 8 | 11 | |||
| Receivables | 73 | 47 | 41 | 63 | 50 | 53 | |||
| Inventory, net of allowances, customer advances and progress billings | 280 | 346 | 400 | 314 | 276 | 296 | |||
| Inventory | 280 | 346 | 400 | 314 | 276 | 296 | |||
| Prepaid expense | 15 | 12 | 7 | 10 | 16 | 6 | |||
| Deferred costs | 10 | 12 | 14 | 11 | 8 | 7 | |||
| Derivative instruments and hedges, assets | 9 | 9 | |||||||
| Deposits current assets | 2 | 1 | 1 | 33 | 1 | 1 | |||
| Other current assets | 18 | 18 | 18 | 15 | 16 | 16 | |||
| Other undisclosed current assets | 27 | 36 | 36 | 33 | 28 | 22 | |||
| Total current assets: | 702 | 760 | 873 | 903 | 740 | 799 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 90 | 99 | 121 | 155 | 144 | ✕ | |||
| Property, plant and equipment | 433 | 445 | 454 | 468 | 454 | 465 | |||
| Intangible assets, net (including goodwill) | 336 | 273 | 283 | 293 | 277 | 287 | |||
| Goodwill | 231 | 206 | 206 | 203 | 197 | 197 | |||
| Intangible assets, net (excluding goodwill) | 105 | 67 | 77 | 90 | 80 | 90 | |||
| Other noncurrent assets | 245 | 244 | 175 | 138 | 154 | 144 | |||
| Total noncurrent assets: | 1,105 | 1,061 | 1,034 | 1,054 | 1,029 | 895 | |||
| TOTAL ASSETS: | 1,806 | 1,821 | 1,906 | 1,957 | 1,769 | 1,694 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 304 | 334 | 422 | 513 | 329 | 370 | |||
| Accounts payable | 44 | 54 | 50 | 66 | 39 | 48 | |||
| Accrued liabilities | 260 | 280 | 372 | 447 | 290 | 323 | |||
| Debt | 25 | 25 | 108 | 30 | 28 | 69 | |||
| Total current liabilities: | 329 | 359 | 530 | 543 | 357 | 440 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 478 | 377 | 358 | 418 | 440 | 361 | |||
| Long-term debt, excluding current maturities | 478 | 377 | 269 | 305 | 334 | 361 | |||
| Liabilities, other than long-term debt | 178 | 187 | 106 | 102 | 97 | 112 | |||
| Other liabilities | 107 | 110 | 106 | 102 | 97 | 112 | |||
| Operating lease, liability | 71 | 77 | 89 | 112 | 106 | ✕ | |||
| Total noncurrent liabilities: | 656 | 564 | 464 | 520 | 537 | 473 | |||
| Total liabilities: | 984 | 924 | 994 | 1,063 | 894 | 913 | |||
| Equity | |||||||||
| Equity, attributable to parent | 822 | 897 | 913 | 894 | 875 | 782 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Treasury stock, value | (1,570) | (1,569) | (1,527) | (1,462) | (1,325) | (1,327) | |||
| Additional paid in capital | 622 | 613 | 602 | 580 | 558 | 553 | |||
| Accumulated other comprehensive loss | (100) | (87) | (74) | (65) | (85) | (80) | |||
| Retained earnings | 1,870 | 1,939 | 1,912 | 1,841 | 1,728 | 1,636 | |||
| Total equity: | 822 | 897 | 913 | 894 | 875 | 782 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,806 | 1,821 | 1,906 | 1,957 | 1,769 | 1,694 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,969 | 2,226 | 2,696 | 2,582 | 2,420 | 2,679 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (612) | (631) | (675) | (658) | (581) | (634) | ||
| Gross profit: | 1,357 | 1,595 | 2,020 | 1,924 | 1,839 | 2,045 | ||
| Operating expenses | (1,309) | (1,484) | (1,786) | (1,666) | (1,572) | (1,804) | ||
| Operating income (loss): | 48 | 111 | 234 | 258 | 267 | 241 | ||
| Nonoperating expense | (22) | (22) | (2) | (1) | (12) | (21) | ||
| Gain (loss), foreign currency transaction, before tax | (1) | (8) | (7) | 0 | (4) | (16) | ||
| Interest and debt expense | (26) | (14) | (11) | (13) | (19) | (7) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1 | 75 | 221 | 243 | 236 | 212 | ||
| Other undisclosed income from continuing operations before income taxes | 26 | 14 | 11 | 13 | 19 | 7 | ||
| Income (loss) from continuing operations before income taxes: | 27 | 89 | 232 | 256 | 255 | 220 | ||
| Income tax expense (benefit) | (18) | 16 | (85) | (65) | (82) | (98) | ||
| Income (loss) from continuing operations: | 9 | 105 | 147 | 191 | 174 | 122 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 147 | 191 | 174 | 122 | |
| Net income (loss) available to common stockholders, diluted: | 9 | 105 | 147 | 191 | 174 | 122 | ||
Comprehensive Income ($ in millions)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 9 | 105 | 147 | 191 | 174 | 122 | ||
| Other comprehensive income (loss) | 1 | (1) | (0) | 0 | 0 | (2) | ||
| Comprehensive income (loss): | 9 | 104 | 147 | 192 | 174 | 120 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (14) | (12) | (9) | 20 | (6) | (11) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (5) | 92 | 138 | 212 | 168 | 108 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.